Original ArticleSpectrophotometric determination of the sulfhydryl containing drug Mesna (cas 19767-45-4)

Add time:09/09/2019    Source:sciencedirect.com

Four simple and sensitive spectrophotometric methods were developed for the determination of the sulfhydryl containing drug mesna (MSN). Methods I and II rely on nucleophilic aromatic substitution reactions using two UV tagging reagents namely: 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) for method I and 2,4-dinitrofluorobenzene (DNFB) for method II. Both reactions took place in alkaline buffered medium and the obtained yellowish products were measured at 414 and 332 nm for methods I and II, respectively. Methods III and IV are indirect spectrophotometric methods based on the suppressive effect of MSN on the absorption of two ternary complex systems which are composed of 1,10-phenanthroline, silver and eosin for method III and 1,10-phenanthroline, silver and bromopyrogallol red for method IV. The decrease in absorbance of the ternary complexes was measured at 547 and 635 nm for methods III and IV, respectively. All the experimental parameters affecting these reactions were carefully studied and optimized. The methods were validated as per the ICH guidelines. The methods were applicable in the linearity ranges 4–18 μg/mL for method I, 4–16 μg/mL for method II, 0.25–2.25 μg/mL for method III and 0.25–1.75 μg/mL for method IV. The proposed methods were successfully applied for the analysis of MSN in its commercial ampoules and no interference was encountered from the present excipients as indicated by the satisfactory percentage recoveries. The results obtained were in a good agreement with those obtained from a previously published method of the investigated drug.

We also recommend Trading Suppliers and Manufacturers of Mesna (cas 19767-45-4). Pls Click Website Link as below: cas 19767-45-4 suppliers

Prev:Cas cliniqueTests épicutanés pour un érythème pigmenté fixe après prise de cyclophosphamide associé au Mesna (cas 19767-45-4)Drug patch tests in the investigation of a fixed drug eruption subsequent to 2 courses of cyclophosphamide in combination with Mesna (cas 19767-45-4)
Next:Urinary Mesna (cas 19767-45-4) and total Mesna (cas 19767-45-4) measurement by high performance liquid chromatography with ultraviolet detection)